BIOSENSE ApS
CVR number: 20830735
Vidågade 28, 6270 Tønder
Biosense@outlook.dk
tel: 50810340
Biosense.dk
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 18.70 | 68.34 | -1.65 | 193.70 | 236.54 |
| Employee benefit expenses | -52.24 | -44.78 | -45.32 | -33.87 | - 193.75 |
| Total depreciation | -13.20 | -13.20 | -13.20 | ||
| EBIT | -46.74 | 10.36 | -60.17 | 159.83 | 42.79 |
| Other financial income | 94.78 | 43.27 | 0.00 | 0.32 | |
| Other financial expenses | -0.12 | -7.56 | -3.07 | -2.50 | -0.86 |
| Pre-tax profit | 47.91 | 46.07 | -63.24 | 157.34 | 42.25 |
| Income taxes | -10.57 | -10.14 | -3.22 | -17.49 | -9.48 |
| Net earnings | 37.35 | 35.93 | -66.46 | 139.85 | 32.76 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 26.40 | 13.20 | |||
| Tangible assets total | 26.40 | 13.20 | |||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 406.30 | 406.30 | 406.30 | 242.70 | 242.70 |
| Inventories total | 406.30 | 406.30 | 406.30 | 242.70 | 242.70 |
| Current trade debtors | 62.97 | 84.98 | 296.56 | ||
| Current other receivables | 3.70 | ||||
| Current deferred tax assets | 20.83 | 3.22 | 2.00 | ||
| Short term receivables total | 83.81 | 3.22 | 5.70 | 84.98 | 296.56 |
| Other current investments | 495.97 | 0.05 | |||
| Cash and bank deposits | 37.78 | 534.92 | 292.09 | 463.20 | 519.23 |
| Cash and cash equivalents | 533.76 | 534.97 | 292.09 | 463.20 | 519.23 |
| Balance sheet total (assets) | 1 050.26 | 957.69 | 704.10 | 790.89 | 1 058.49 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 110.60 | 113.00 | 114.40 | ||
| Retained earnings | 656.40 | 580.75 | 502.28 | 435.82 | 575.67 |
| Profit of the financial year | 37.35 | 35.93 | -66.46 | 139.85 | 32.76 |
| Shareholders equity total | 929.35 | 854.68 | 675.22 | 700.67 | 733.43 |
| Non-current liabilities total | |||||
| Current trade creditors | 10.00 | 18.76 | 19.09 | 14.58 | 29.53 |
| Current owed to participating | 78.84 | 0.06 | 0.06 | 0.06 | |
| Short-term deferred tax liabilities | 5.22 | 17.49 | 9.48 | ||
| Other non-interest bearing current liabilities | 32.08 | 79.03 | 9.73 | 58.09 | 285.99 |
| Current liabilities total | 120.92 | 103.02 | 28.88 | 90.22 | 325.06 |
| Balance sheet total (liabilities) | 1 050.26 | 957.69 | 704.10 | 790.89 | 1 058.49 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.